Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.
Open | $83.920 |
Close | $85.350 |
Volume / Avg. | 593.876K / 445.776K |
Day Range | 83.670 - 85.450 |
52 Wk Range | 70.740 - 95.260 |
Market Cap | $4.335B |
P/E Ratio | 34.183 |
Dividend Yield | - |
Exchange | NYSE |
RSI | 72 |
Short Interest | 6.53% |
Days to Cover | 4.71 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.
Other companies in Haemonetics’s space includes: RxSight (NASDAQ:RXST), TELA Bio (NASDAQ:TELA), Meihua Intl Medical Techs (NASDAQ:MHUA), Embecta (NASDAQ:EMBC) and NexGel (NASDAQ:NXGL).
The latest price target for Haemonetics (NYSE: HAE) was reported by Barrington Research on Tuesday, February 13, 2024. The analyst firm set a price target for 105.00 expecting HAE to rise to within 12 months (a possible 23.02% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Haemonetics (NYSE: HAE) is $85.35 last updated March 28, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Haemonetics.
Haemonetics’s Q3 earnings are confirmed for Tuesday, February 7, 2023.
There is no upcoming split for Haemonetics.
Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.